Effect of homocysteine concentration in early pregnancy on gestational hypertensive disorders and other pregnancy outcomes

Clinical Chemistry

Volumn 54, Issue 2, 2008, Pages 326-334

  Dodds, Linda ^a,c   Fell, Deshayne B ^a   Dooley, Kent C ^a   Armson, B Anthony ^a   Allen, Alexander C ^a   Nassar, Bassam A ^a   Perkins, Sherry ^b   Joseph, K S ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c IWK HEALTH CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HOMOCYSTEINE;

ADULT; ARTICLE; BLOOD SAMPLING; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HUMAN; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; MEDICAL RECORD; PREECLAMPSIA; PREGNANCY OUTCOME; PROSPECTIVE STUDY; PROTEIN DETERMINATION; QUESTIONNAIRE; RISK FACTOR;

ABORTION, SPONTANEOUS; FEMALE; HOMOCYSTEINE; HUMANS; HYPERTENSION, PREGNANCY-INDUCED; INFANT, NEWBORN; INFANT, SMALL FOR GESTATIONAL AGE; PRE-ECLAMPSIA; PREGNANCY; RISK FACTORS;

EID: 39749185354     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2007.097469     Document Type: Article

References (32)

1. Mignini LE, Latthe PM, Villar J, Kilby MD, Carroli G, Khan KS. Mapping the theories of preeclampsia: the role of homocysteine. Obstet Gynecol 2005;105:411-25.
2. Murakami S, Matsubara N, Saitoh M, Miyakaw S, Shoji M, Kubo T. The relation between plasma homocysteine concentration and methylenetetrahydrofolate reductase gene polymorphism in pregnant women. J Obstet Gynaecol Res 2001;27:349-52.
3. Onalan R, Onalan G, Gunenc Z, Karabulut E. Combining 2nd-trimester maternal serum homocysteine concentrations and uterine artery Doppler for prediction of preeclampsia and isolated intrauterine growth restriction. Gynecol Obstet Invest 2006;61:142-8.
4. Cotter AM, Molloy AM, Scott JM, Daly SF. Elevated plasma homocysteine in early pregnancy: a risk factor for the development of nonsevere preeclampsia. Am J Obstet Gynecol 2003;189:391,4; discussion 394-6.
5. Cotter AM, Molloy AM, Scott JM, Daly SF. Elevated plasma homocysteine in early pregnancy: a risk factor for the development of severe preeclampsia. Am J Obstet Gynecol 2001;185:781-5.
6. Sorensen TK, Malinow MR, Williams MA, King IB, Luthy DA. Elevated second-trimester serum homocyst(e)ine levels and subsequent risk of preeclampsia. Gynecol Obstet Invest 1999;48:98-103.
7. Vollset SE, Refsum H, Irgens LM, Emblem BM, Tverdal A, Gjessing HK, et al. Plasma total homocysteine, pregnancy complications, and adverse pregnancy outcomes: the Hordaland Homocysteine Study. Am J Clin Nutr 2000;71:962-8.
8. Makedos G, Papanicolaou A, Hitoglou A, Kalogiannidis I, Makedos A, Vrazioti V, et al. Homocysteine, folic acid and B12 serum levels in pregnancy complicated with preeclampsia. Arch Gynecol Obstet 2007;275:121-4.
9. D'Anna R, Baviera G, Corrado F, Ientile R, Granese D, Stella NC. Plasma homocysteine in early and late pregnancies complicated with preeclampsia and isolated intrauterine growth restriction. Acta Obstet Gynecol Scand 2004;83:155-8.
10. Hogg BB, Tamura T, Johnston KE, Dubard MB, Goldenberg RL. Second-trimester plasma homocysteine levels and pregnancy-induced hypertension, preeclampsia, and intrauterine growth restriction. Am J Obstet Gynecol 2000;183:805-9.
11. Nelen WL, Blom HJ, Steegers EA, den Heijer M, Thomas CM, Eskes TK. Homocysteine and folate levels as risk factors for recurrent early pregnancy loss. Obstet Gynecol 2000;95:519-24.
12. Ray JG, Laskin CA. Folic acid and homocyst(e)ine metabolic defects and the risk of placental abruption, pre-eclampsia and spontaneous pregnancy loss: a systematic review. Placenta 1999;20:519-29.
13. Aubard Y, Darodes N, Cantaloube M. Hyperhomocysteinemia and pregnancy: review of our present understanding and therapeutic implications. Eur J Obstet Gynecol Reprod Biol 2000;93:157-65.
14. Welch GN, Loscalzo J. Homocysteine and atherothrombosis. N Engl J Med 1998;338:1042-50.
15. Dunn J, Title LM, Bata I, Johnstone DE, Kirkland SA, O'Neill BJ, et al. Relation of a common mutation in methylenetetrahydrofolate reductase to plasma homocysteine and early onset coronary artery disease. Clin Biochem 1998;31:95-100.
16. Helewa ME, Burrows RF, Smith J, Williams K, Brain P, Rabkin SW. Report of the Canadian hypertension society consensus conference: 1. Definitions, evaluation and classification of hypertensive disorders in pregnancy. CMAJ 1997;157:715-25.
17. Kramer MS, Platt RW, Wen SW, Joseph KS, Allen A, Abrahamowicz M, et al. A new and improved population-based Canadian reference for birth weight for gestational age. Pediatrics 2001;108:E35.
18. Walker MC, Smith GN, Perkins SL, Keely EJ, Garner PR. Changes in homocysteine levels during normal pregnancy. Am J Obstet Gynecol 1999;180:660-4.
19. Harland BF. Caffeine and nutrition. Nutrition 2000;16:522-6.
20. Hietala R, Turpeinen U, Laatikainen T. Serum homocysteine at 16 weeks and subsequent preeclampsia. Obstet Gynecol 2001;97:527-9.
21. Wald NJ, Watt HC, Law MR, Weir DG, McPartlin J, Scott JM. Homocysteine and ischemic heart disease: results of a prospective study with implications regarding prevention. Arch Intern Med 1998;158:862-7.
22. Hankey GJ, Eikelboom JW. Homocysteine and vascular disease. Lancet 1999;354:407-13.
23. Moat SJ, McDowell IF. Homocysteine and endothelial function in human studies. Semin Vasc Med 2005;5:172-82.
24. Wareing M, Baker PN. The role of the endothelium. In: Critchley H, MacLean A, Poston L and Walker J, eds. Pre-eclampsia. London: RCOG Press, 2003;113-33.
25. Infante-Rivard C, Rivard GE, Gauthier R, Theoret Y. Unexpected relationship between plasma homocysteine and intrauterine growth restriction. Clin Chem 2003;49:1476-82.
26. Ness RB, Sibai BM. Shared and disparate components of the pathophysiologies of fetal growth restriction and preeclampsia. Am J Obstet Gynecol 2006;195:40-9.
27. Homocysteine Lowering trialists' Collaboration. Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomised trials. BMJ 1998;316:894-8.
28. Jacques PF, Selhub J, Bostom AG, Wilson PW, Rosenberg IH. The effect of folic acid fortification on plasma folate and total homocysteine concentrations. N Engl J Med 1999;340:1449-54.
29. Villar J, Carroli G, Wojdyla D, Abalos E, Giordano D, Ba'aqeel H, et al. Preeclampsia, gestational hypertension and intrauterine growth restriction, related or independent conditions? Am J Obstet Gynecol 2006;194:921-31.
30. Saudan P, Brown MA, Buddle ML, Jones M. Does gestational hypertension become pre-eclampsia? Br J Obstet Gynaecol 1998;105:1177-84.
31. Elshorbagy AK, Oulhaj A, Konstantinova S, Nurk E, Ueland PM, Tell GS, et al. Plasma creatinine as a determinant of plasma total homocysteine concentrations in the Hordaland Homocysteine Study: use of statistical modeling to determine reference limits. Clin Biochem 2007;40:1209-18.
32. Nurk E, Tell GS, Nygard O, Refsum H, Ueland PM, Vollset SE. Plasma total homocysteine is influenced by prandial status in humans: the Hordaland Homocysteine Study. J Nutr 2001;131:1214-6.